Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does LYMECYCLINE Cause Pulmonary embolism? 8 Reports in FDA Database

Visibly Younger Skin in Weeks

Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.

Discover Synevra

According to the FDA Adverse Event Reporting System (FAERS), 8 reports of Pulmonary embolism have been filed in association with LYMECYCLINE. This represents 4.6% of all adverse event reports for LYMECYCLINE.

8
Reports of Pulmonary embolism with LYMECYCLINE
4.6%
of all LYMECYCLINE reports
0
Deaths
0
Hospitalizations

How Dangerous Is Pulmonary embolism From LYMECYCLINE?

Of the 8 reports, and 8 (100.0%) were considered life-threatening.

Is Pulmonary embolism Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for LYMECYCLINE. However, 8 reports have been filed with the FAERS database.

What Other Side Effects Does LYMECYCLINE Cause?

Drug ineffective (16) Product use in unapproved indication (16) Headache (12) Thrombocytopenia (11) Myocarditis (10) Chest pain (9) Hypersensitivity (9) Cholestasis (8) Contraindicated product administered (8) Dry skin (8)

What Other Drugs Cause Pulmonary embolism?

RIVAROXABAN (3,282) LENALIDOMIDE (2,976) APIXABAN (2,714) ETHINYL ESTRADIOL\ETONOGESTREL (2,370) TESTOSTERONE (2,043) RITUXIMAB (1,764) ADALIMUMAB (1,663) PREDNISONE (1,586) METHOTREXATE (1,508) DEXAMETHASONE (1,336)

Which LYMECYCLINE Alternatives Have Lower Pulmonary embolism Risk?

LYMECYCLINE vs LYRICA LYMECYCLINE vs LYSERGIDE LYMECYCLINE vs MABTHERA LYMECYCLINE vs MACITENTAN LYMECYCLINE vs MACITENTAN\TADALAFIL

Related Pages

LYMECYCLINE Full Profile All Pulmonary embolism Reports All Drugs Causing Pulmonary embolism LYMECYCLINE Demographics